4//SEC Filing
O'Brien Ronan 4
Accession 0001062993-21-012392
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:24 PM ET
Size
13.2 KB
Accession
0001062993-21-012392
Insider Transaction Report
Form 4
O'Brien Ronan
General Counsel & Secretary
Transactions
- Award
Stock Option (Right to Buy)
2021-12-03+44,172→ 44,172 totalExercise: $1.29Exp: 2031-01-26→ Common Stock (44,172 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+279,757→ 279,757 totalExercise: $0.72Exp: 2028-03-21→ Common Stock (279,757 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+58,896→ 58,896 totalExercise: $1.08Exp: 2029-03-14→ Common Stock (58,896 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+88,343→ 88,343 totalExercise: $1.09Exp: 2030-03-24→ Common Stock (88,343 underlying)
Footnotes (8)
- [F1]25% of the shares underlying the option vested or shall vest on March 1, 2019 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each one month period thereafter.
- [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 190,000 shares of common stock of Private Pear for $1.05 per share.
- [F3]25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 40,000 shares of common stock of Private Pear for $1.58 per share.
- [F5]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 60,000 shares of common stock of Private Pear for $1.60 per share.
- [F7]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F8]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.89 per share.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881064
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:24 PM ET
- Size
- 13.2 KB